Maravai LifeSciences
MRVI
$7.70
Share price
1.58%
Change (1 day)
-44.16%
Change (1 year)
Categories
Maravai LifeSciences (MRVI) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $0.69 B
According to Maravai LifeSciences 's latest financial reports the company's total liabilities are $0.69 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Maravai LifeSciences - Total liabilities on balance sheet (from 2019 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $0.69 B | -49.34% |
| 2022-12-31 | $1.37 B | 0.3% |
| 2021-12-31 | $1.37 B | 23.03% |
| 2020-12-31 | $1.11 B | 157.62% |
| 2019-12-31 | $0.43 B | 10.6% |
| 2018-12-31 | $0.39 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | $2.69 M | -99.61% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | $0.12 B | -82.51% | 🇬🇧 UK |
 Novavax NVAX | $2.51 B | 260.46% | 🇺🇸 USA |
 Novocure
NVCR | $0.78 B | 12.34% | Jersey |